Biotricity Inc (BTCY) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biotricity Inc   (BTCY)

Biotricity Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Biotricity Inc in the third quarter 2026?
Due to the lack of equity, it was not possible to calculate Biotricity Inc 's return on equity (ROE) in its third quarter 2026

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter		 (Mar 31 2025)
IV. Quarter		 (Dec 31 2024)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -4 -5 -5 -11 -14
Return On Equity (TTM) - - - - -
BTCY's Total Ranking # # # # #
Equity (TTM) in Millions -32 -33 -33 -32 -31
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to BTCY Management Effectiveness >> BTCY's 5 Years Annual ROE >> Compare BTCY ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





BTCY Annual Return On Equity (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2022)
2022		 (Mar 31 2021)
2021
Total Equity in Millions -32 -31 -20 -2 -7
Y / Y Equity Change - - - - -
Net Income in Millions -11 -14 -19 -29 -15
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to BTCY Management Effectiveness >> BTCY's 5 Years Annual ROE >> Compare BTCY ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BTCY's' Return on Equity at Yahoo Finance
BTCY's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BTCY's Competitors
Subscribers only: Roe for Biotricity Inc 's Suppliers
Subscribers only: Return On Equity for BTCY's Customers




Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector ROE
Vaxart Inc   33.83 %
Johnson and Johnson  33.78 %
Dexcom Inc   32.44 %
Phibro Animal Health Corporation  32.06 %
Innoviva Inc   30.60 %
Pro dex Inc   30.23 %
Novartis Ag  30.00 %
Incyte Corporation  29.15 %
Waters Corporation  28.52 %
Puma Biotechnology Inc   27.81 %
Resmed Inc   25.18 %
Encompass Health Corporation  24.76 %
Prestige Consumer Healthcare Inc   24.66 %
Catalyst Pharmaceuticals Inc   24.32 %
Collegium Pharmaceutical Inc   24.11 %
Xoma Royalty Corporation  23.97 %
Chemed Corporation  23.92 %
Iradimed Corporation  23.83 %
Lifevantage Corp  23.04 %
Hims and Hers Health Inc   22.99 %
Vertex Pharmaceuticals Inc  22.70 %
Pacs Group Inc   22.54 %
Spero Therapeutics Inc   22.53 %
Iqvia Holdings Inc   22.05 %
Ge Healthcare Technologies Inc   21.90 %
Msa Safety Inc  21.82 %
Mimedx Group Inc   21.24 %
Universal Health Services Inc   21.19 %
Inspire Medical Systems inc   21.07 %
Astrazeneca Plc  21.00 %

Date modified: 2026-09-12T06:20:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.